Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Psychiatric Rehabilitation 2Irinotecan 2transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1ribociclib 1lonafarnib 1laromustine 1emvododstat 1Vinorelbine 1Vincristine 1Valproic Acid 1Topotecan 1Temozolomide 1Semaxinib 1Oxaliplatin 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Everolimus 1Drug Therapy 1Busulfan 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Familial ependymoma × Valproic Acid × Clear all
NCT00107458 2014-08-07

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡